Oral Biologics and Access

Analyze how regulatory frameworks for novel drug formulations (such as oral versions of biologic therapies) influence patient access, pricing, and incentives for pharmaceutical innovation. Compare different regulatory strategies, potential risks, and ethical considerations. Propose a framework for evaluating access versus innovation.